Helix Biopharma AACR-NCI-EORTC International Molecular Targets
Helix Biopharma Corp.
Announces fiscal Year-End Result 2023
Who We Are?
We are a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology for the prevention and treatment of cancer based on our proprietary technological platform DOS47.
DOS47 – Confirmed Mechanism of Action
Our Technology
![](https://www.helixbiopharma.com/wp-content/uploads/2023/10/20231020_095143-scaled-e1701758551372-1024x738.jpg)
Wah Wong (left) analysing protein expression data using the Guava® flow cytometer and Baomin Tian (right) analysing images of protein samples in SDS-PAGE gel on Bio-Rad Gel Doc™ XR+ system.
![](https://www.helixbiopharma.com/wp-content/uploads/2023/10/20231020_092800-1024x733.jpg)
Baomin Tian removing unreacted reagents from a protein conjugation reaction solution with a G20 desalting column.
![](https://www.helixbiopharma.com/wp-content/uploads/2023/11/20231020_092800-768x5501-1.png)
Wah Wong checking the growth of tumor cell culture under the microscope.
.
![](https://www.helixbiopharma.com/wp-content/uploads/2023/10/20231020_093703-scaled-e1701760790288-1024x732.jpg)
Iain Wilson replacing a check valve on the Acquity UPLC, part of the Waters Xevo G2QTof mass spectrometer system
![](https://www.helixbiopharma.com/wp-content/uploads/2023/11/20231020_092800-768x5502-1.png)
Wah Wong pipetting culture medium into a 96-well tissue culture plate inside a biological safety cabinet.
![](https://www.helixbiopharma.com/wp-content/uploads/2023/11/20231020_092800-768x5503-1.png)
Baomin Tian analysing mass spectrometry data, mapping peptides from protein samples, on a Waters UNIFI workstation.
![](https://www.helixbiopharma.com/wp-content/uploads/2023/11/20231020_092800-768x5504-1.png)
Iain Wilson streaking a LB-kanamycin agar plate with E. coli cells that were transformed with plasmid DNA inside a biological safety cabinet.
![](https://www.helixbiopharma.com/wp-content/uploads/2023/11/20231020_092800-768x5505-1.png)
Wah Wong (left) analysing protein expression data using the Guava® flow cytometer.